Eton Pharmaceuticals is a specialty pharmaceutical company focused on developing and commercializing pharmaceutical products utilizing the FDA's 505(b)(2) regulatory pathway. The company's product candidates focuses on liquid formulation, including injectables, oral liquids, and ophthalmics. The company's formula products include: EM-100, an ophthalmic solution indicated for the treatment of allergic conjunctivitis; ET-202, an injectable product candidate to be used in the hospital setting; ET-103, an oral liquid formulation of levothyroxine for the treatment of hypothyroidism; and ET-203, an injectable product candidate to be used in the hospital setting.

Tile Shop Holdings is a holding company. Through its subsidiaries, the company is a retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the U.S. The company provides a range of natural stone and man-made tile products, sourced directly from its suppliers. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, and metal tiles. The company's accessories, including trim pieces, mosaics, pencils, listellos, and other products. The company also provides a range of setting and maintenance materials, such as thinset, grout, sealers, and accessories.